Schaeffler
German automotive-components group investing in and buying from Humanoid.
Schaeffler, the German automotive-components group, took equity in Humanoid's $152m Series A on 21 July 2026, committing its own factories to a wheeled-robot deployment the two firms describe as the biggest commercial agreement the sector has publicly disclosed, while separately backing rival Neura Robotics.
Last refreshed: 31 July 2026 · Appears in 1 active topic
Schaeffler backs two rival humanoid robot makers: is that strategy or hedging?
Timeline for Schaeffler
Mentioned in: Dealroom projects $34.2bn for UK tech
UK Startups and InnovationSigned a commercial agreement to deploy thousands of HMND 01 robots
UK Startups and Innovation: Humanoid's buyers wrote the $152m chequeBackground
Schaeffler is a German automotive and industrial components group, long focused on bearings, drivetrain parts and precision engineering for car makers and heavy industry. Robotics investment marks a newer strand of its strategy, positioning the company to secure both technology access and future demand as manufacturers automate factory floors.
Taking equity stakes in robotics makers it also buys from lets Schaeffler shape product development toward its own manufacturing needs while sharing the financial risk of unproven platforms with other investors. Holding stakes in more than one Humanoid-robot maker at once spreads that bet further, at the cost of undivided commercial loyalty to any single supplier.
The approach mirrors that of other automotive and industrial groups moving from being customers of automation technology to co-owners of it.
Schaeffler hedges bets across rival robots
Schaeffler took equity in Humanoid's $152m Series A on 21 July 2026 and committed its own manufacturing sites to deploying wheeled HMND 01 units, a deal the two firms bill as the biggest commercial robotics agreement disclosed to date, though Schaeffler has released no unit count or delivery date.
Schaeffler holds the identical investor-customer role at German rival Neura Robotics, valued at roughly $7bn a month before Humanoid's round, giving the group simultaneous stakes in two competing Humanoid makers. That concentration reads less as a single bet than as an industrial strategy to secure supply and influence across whichever robotics platform proves out first on a real factory floor.